Overview

Tech Summary

Promoter Holding

Posts

PFIZER

30123456789,401234567896012345678970123456789.1012345678950123456789
-35.45 (-1.01%)
The current prices are delayed.Login/Sign Up to see live prices.
Previous Close: 3502.6
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
3451.3
Today's high
3502.05
52 week low
3408
52 week high
3833.95
Volume
13126
About
Tech Summary
DMA(12)
₹4129
DMA(50)
₹4272.39
DMA(100)
₹4343.53
DMA(200)
₹4807.09
Fund Summary
Market Cap
₹15844.88 Cr.
Enterprise Value
₹15844.88 Cr.
No. of Shares
4.57
P/E
115.68
RoE
Debt/Equity
Valuations
PE Chart
303540
PB Chart
Promoter Holdings
Public : 18.38%
FII : 2.77%
DII : 14.93%
Promoter : 63.92%
Others : 0%
Charts
Debt/Equity
ROE vs ROCE
Revenue vs Profitability (1000Cr.)
Margins(%)
About
Hero Img
Create your account on Frontpage
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Stock Sentiments
100% Bullish
0% Bearish
16 live trades of Rs. 545,394.1
T
tannu757
 
Reputation: 0 • 
Yesterday 2:47 PM
PFIZER
100 Qty (S) Exited₹430
T
tannu757
 
Reputation: 0 • 
Mar 28 8:41 PM
PFIZER
100 Qty (S) Exited₹1,580
Posts by FrontPage Users
NewsBot-display-image
Reputation: 35,254  •  Yesterday 7:36 PM
Global dealmaking sinks to lowest level in over a decade
Global dealmaking sinks to lowest level in over a decade
A banking crisis that started in the United States this month with Silicon Valley Bank and spread to Europe with the Swiss government-orchestrated sale of Credit Suisse Group AG to UBS Group AG roiled markets and stopped many deals in their tracks, investment bankers and lawyers said.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Mar 31 12:26 AM
Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV's HIV preventive therapy
Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV's HIV preventive therapy
Through the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic versions of cabotegravir LA for PrEP, in 90 countries, subject to required regulatory approvals. Aurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Mar 30 6:11 AM
Viatris puts India API business on the block
Viatris puts India API business on the block
However, the API sale process, which was launched a couple of months ago, has seen no serious buyers, added multiple people aware of the development. The company has been seeking a valuation of $600-700 million (₹5,000 crore) for the API business and hired Jefferies to run the sale process.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Mar 14 6:13 PM
Rationale behind Pfizer’s $43 billion acquisition of loss-making Seagen- unleashing guided missiles against Cancer
Rationale behind Pfizer’s $43 billion acquisition of loss-making Seagen- unleashing guided missiles against Cancer
With a post-COVID record profit, Pfizer is looking to double down on cancer treatments in anticipation of the upcoming surge in cases.
Moneycontrol
Comment
Share
Add a comment
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Mar 14 1:11 PM
Sliding bank shares drag Wall Street down in choppy trade
Sliding bank shares drag Wall Street down in choppy trade
"The market is now expecting that the Fed is likely to not raise rates this month and so they may enter a pause period," said Peter Cardillo, chief market economist at Spartan Capital Securities.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Feb 28 2:36 PM
US stocks close slightly up after prior week's selloff
US stocks close slightly up after prior week's selloff
All three main stock indexes climbed more than 1% shortly after the opening bell, in part due to an easing in Treasury yields, and all three closed well off their session highs.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Feb 16 8:38 PM
Buy Pfizer India; target of Rs 4800: Anand Rathi
Buy Pfizer India; target of Rs 4800: Anand Rathi
Anand Rathi is bullish on Pfizer India has recommended buy rating on the stock with a target price of Rs 4800 in its research report dated February 10, 2023.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Feb 10 12:41 PM
Stocks in news: Zomato, LIC, M&M, HAL, Adani group companies
Stocks in news: Zomato, LIC, M&M, HAL, Adani group companies
Food delivery giant Zomato's net loss widened to Rs 347 core compared with a loss of 63 crore a year ago. Consolidated revenue from operations surged 75% on year to Rs 1,948 crore.
The Economic Times
Comment
Share
Add a comment
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Dec 13, 2022 1:11 PM
US stock market: Wall Street rallies with inflation, Fed on tap
US stock market: Wall Street rallies with inflation, Fed on tap
Consumer inflation data will be closely monitored on Tuesday, and is expected to show prices increased by 7.3% in November on an annual basis, slowing from the 7.7% rise in the previous month, while the "core" reading which excludes food and energy is expected to show a 6.1% increase from the 6.3% in the prior month.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Dec 13, 2022 12:41 PM
SGX Nifty up 20 points; here's what changed for market while you were sleeping
SGX Nifty up 20 points; here's what changed for market while you were sleeping
U.S. stock indexes rallied to kick off the trading week on Monday, lifted in part by gains in Microsoft and Pfizer, as investors girded for inflation data on Tuesday and a policy announcement from the Federal Reserve later in the week.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Dec 1, 2022 5:51 PM
Buy Pfizer, target price Rs 5250:  Anand Rathi
Buy Pfizer, target price Rs 5250: Anand Rathi
Pfizer, incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20966.41 Crore) operating in Pharmaceuticals sector.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Nov 22, 2022 4:23 AM
Hold Pfizer; target of Rs 4505: ICICI Direct
Hold Pfizer; target of Rs 4505: ICICI Direct
ICICI Direct recommended hold rating on Pfizer with a target price of Rs 4505 in its research report dated November 17, 2022.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Nov 18, 2022 3:46 PM
Hold Pfizer, target price Rs 4505:  ICICI Direct
Hold Pfizer, target price Rs 4505: ICICI Direct
Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20569.10 Crore) operating in Pharmaceuticals sector.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Oct 22, 2022 2:51 PM
Stocks end higher on Wall Street, notching weekly gains
Stocks end higher on Wall Street, notching weekly gains
The Fed is expected to raise interest rates another three-quarters of a percentage point at its upcoming meeting in November. Markets have been unsettled partly because investors have been hoping that any sign of inflation easing or economic growth slowing could signal that the Fed will ease up on its rate increases, which have yet to show any signs of significantly impacting inflation.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Oct 11, 2022 12:03 PM
Hot Stocks | RPG Life, Krishna Institute of Medical Sciences, Pfizer can give healthy returns in short term. Here's why
Hot Stocks | RPG Life, Krishna Institute of Medical Sciences, Pfizer can give healthy returns in short term. Here's why
Indicators and oscillators like MACD (moving average convergence and divergence) and RSI have turned bullish on the weekly charts. KIMS is placed above all important moving averages, indicating bullish trend on all time frames.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Oct 6, 2022 3:26 PM
Stocks to buy or sell: 8 short-term trading ideas by experts for 6 October 2022
Stocks to buy or sell: 8 short-term trading ideas by experts for 6 October 2022
And whenever there is a rally in US markets, India is outperforming reflecting the resilience of Indian economy and markets. Investors should not be carried away by the rallies because there are major challenges for the global economy and markets.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Oct 6, 2022 2:11 PM
Buy Pfizer, target price Rs 4725:  HDFC Securities
Buy Pfizer, target price Rs 4725: HDFC Securities
Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Scrap for the year ending 31-Mar-2022.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Oct 3, 2022 5:16 PM
Hold Pfizer, target price Rs 4480:  ICICI Direct
Hold Pfizer, target price Rs 4480: ICICI Direct
Pfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 19287.47 Crore) operating in Pharmaceuticals sector.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Sep 12, 2022 12:48 PM
Hot Stocks | Here's why you should bet on ONGC, Gujarat Gas, Pfizer for short term
Hot Stocks | Here's why you should bet on ONGC, Gujarat Gas, Pfizer for short term
Recently on a weekly scale, Gujarat Gas confirmed a bullish Inverted Hammer candlestick pattern followed by a bullish Piercing pattern exactly at the mentioned support levels and that is adding more confirmation of further upside in the counter.
Moneycontrol
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Sep 3, 2022 11:21 PM
UK approves Pfizer bivalent Covid vaccine ahead of booster drive
UK approves Pfizer bivalent Covid vaccine ahead of booster drive
The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved the Pfizer jab as a booster for those aged 12 and over after a "careful review of the evidence". The UK regulator last month okayed a similar bivalent vaccine by Moderna, becoming the first country to do so. MHRA chief executive June Raine said: "I am pleased to announce that we now have a second approved vaccine for the UK Autumn booster programme."
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Sep 3, 2022 2:36 AM
'Completely new' Covid strains possible this winter: EU
'Completely new' Covid strains possible this winter: EU
It will include a mix of newly-approved jabs adapted for the now dominant Omicron strain, and the original vaccines developed to fight the virus that first emerged in China in 2019, the European Medicines Agency (EMA) said. But people "should not wait for a specific vaccine", EMA vaccines chief Marco Cavaleri told a news conference.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Sep 2, 2022 5:46 AM
Biological E's Pneumonia jab for kids gets nod
Biological E's Pneumonia jab for kids gets nod
​​Streptococcus pneumoniae infection is a leading cause of child mortality under 5 years of age in India and other developing countries.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Sep 1, 2022 11:21 PM
BE's pediatric pneumonia jab gets CDSCO expert panel approval
BE's pediatric pneumonia jab gets CDSCO expert panel approval
The BE's pneumococcal conjugate vaccine (PCV) can be administered to infants at 6, 10 and 14 weeks of age. Streptococcus pneumoniae infection continues to be a leading cause of child mortality under 5 years of age in India and in developing countries.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Sep 1, 2022 8:36 PM
Dr Anthony Fauci sounds alarm bells for 'bad flu season' as he nears office exit. Read more for details
Dr Anthony Fauci sounds alarm bells for 'bad flu season' as he nears office exit. Read more for details
Chief Medical Advisor to the President of United States Dr Anthony Fauci advises people to get shots for Covid and flu ASAP. He also plans to encourage HIV shots. While alarming citizens, he asks the US to pay heed to the warning signs.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 27, 2022 8:26 PM
US first lady Jill Biden tests positive for COVID-19. Check out the details
US first lady Jill Biden tests positive for COVID-19. Check out the details
The first lady of United States, Jill Biden, has tested positive for COVID-19 again, the White House said on Wednesday.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 27, 2022 1:01 AM
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
Moderna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before COVID-19 emerged in 2019 and exploded into global consciousness in early 2020. Moderna has also been sued for patent infringement in the United States and has an ongoing dispute with the U.S. National Institutes of Health over rights to mRNA technology.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 26, 2022 3:41 PM
Countries with lower income faced 'systemic racism' in global Covid response: Report
Countries with lower income faced 'systemic racism' in global Covid response: Report
A combination of undersupply of vaccines and treatments, underfunding of health systems, undervaluing of health workers, and poor adaptation to local needs were the key drivers behind low vaccination rates, informed researchers studying communities in 14 low and middle-income countries and territories.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 25, 2022 5:16 PM
Indian vaccine makers gaining wider market share in industry
Indian vaccine makers gaining wider market share in industry
According to a TOI report, indigenously-manufactured vaccines have started to capture share from MNCs in certain diseases even as the Rs 3,000 crore private market plummeted sharply by 15% in June month-on-month, one of the sharpest such declines in recent years.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 25, 2022 2:31 AM
WHO: COVID deaths down by 15%, cases fall nearly everywhere
WHO: COVID deaths down by 15%, cases fall nearly everywhere
In its latest weekly assessment of the COVID-19 pandemic, the U.N. health agency said there were 5.3 million new cases and more than 14,000 deaths reported last week. WHO said the number of new infections declined in every world region except the Western Pacific.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 24, 2022 3:16 AM
AstraZeneca may not stay in vaccines, but CEO has no COVID regrets
AstraZeneca may not stay in vaccines, but CEO has no COVID regrets
Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures - in October 2012, following a stint at pharma peer Roche. With the Frenchman at the helm, the fortunes of the Anglo-Swedish drugmaker changed dramatically.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 24, 2022 1:01 AM
AstraZeneca on hunt for acquisitions, says CEO Pascal Soriot
AstraZeneca on hunt for acquisitions, says CEO Pascal Soriot
Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures - in October 2012, following a stint at pharma peer Roche.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 23, 2022 10:01 PM
Pfizer-BioNTech COVID shot 73.2% effective in kids under 5
Pfizer-BioNTech COVID shot 73.2% effective in kids under 5
Pfizer and BioNTech's vaccine was authorized for children under 5 years of age in June, based on data that showed the vaccine generated a similar immune response to those seen in older age groups. An early analysis based on 10 symptomatic COVID-19 cases in the study had suggested a vaccine efficacy of 80.3% in this group.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 23, 2022 10:11 AM
Novavax's protein-based jab offers better immunity against new variants: CEO Stanley Erck
Novavax's protein-based jab offers better immunity against new variants: CEO Stanley Erck
Novavax's protein-based vaccine was approved for emergency use by the US Food and Drug Administration (USFDA) last month in India.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 17, 2022 7:31 PM
Sanofi trial failure ends development of breast cancer treatment amcenestrant
Sanofi trial failure ends development of breast cancer treatment amcenestrant
A trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an independent monitoring panel found no signs of it working. "All other studies of amcenestrant, including in early-stage breast cancer (AMEERA-6), will be discontinued," Sanofi said.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 15, 2022 11:21 PM
Pfizer CEO Albert Bourla tests positive for Covid, says has very mild symptoms
Pfizer CEO Albert Bourla tests positive for Covid, says has very mild symptoms
Pfizer Inc Chief Executive Officer Albert Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions. Paxlovid is an antiviral medication that is used to treat high-risk patients, such as older people.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 13, 2022 5:01 AM
Innovation in focus: How India can become a global R&D powerhouse
Innovation in focus: How India can become a global R&D powerhouse
Make in India can be made better by shifting focus to employment in more labour-intensive industries, increasing India's global trade competitiveness and by GoI fully embracing an ancillary 'Innovate in India' campaign focused on facilitating India's rise as a global R&D hub and generating employment for high-skill workers.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 10, 2022 6:21 PM
Drug firm Pfizer's Managing Director S Sridhar resigns
Drug firm Pfizer's Managing Director S Sridhar resigns
He will continue to serve in his current position until the identification, selection and transition to the new leadership takes place in the company, it added.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 10, 2022 1:31 AM
Lyme disease vaccine: Major test underway. All you need to know
Lyme disease vaccine: Major test underway. All you need to know
After twenty years, there is a possibility that a vaccine against Lyme disease will be ready. People are being tested for its efficacy in both Europe and the USA.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 9, 2022 3:33 AM
Hold Pfizer; target of Rs 4480: ICICI Direct
Hold Pfizer; target of Rs 4480: ICICI Direct
ICICI Direct recommended hold rating on Pfizer with a target price of Rs 4480 in its research report dated August 06, 2022.
Moneycontrol
Comment
Share
Add a comment
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Aug 5, 2022 11:06 PM
Pfizer Q1 Results: Profit falls 83% to Rs 33 crore
Pfizer Q1 Results: Profit falls 83% to Rs 33 crore
Revenue from operations declined to Rs 593 crore in the quarter from Rs 749 crore in the year-ago period.The drug firm said exceptional items for June quarter comprised Rs 130 crore on account of a voluntary retirement scheme and Rs 6 crore for restructuring to drive business transformation.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Jul 30, 2022 12:26 AM
US reaches deal with Moderna for omicron Covid 19 vaccine
US reaches deal with Moderna for omicron Covid 19 vaccine
The order of the bivalent shot follows the announcement last month that the federal government had secured 105 million doses of a similar vaccine from rival drugmaker Pfizer. Both orders are scheduled for delivery in the fall and winter, assuming regulators sign off on their effectiveness. The Pentagon said the Moderna contract was worth $1.74 billion.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Jul 29, 2022 6:21 AM
Zenara Gets Nod to Manufacture, Sell Pfizer's Paxlovid
Zenara Gets Nod to Manufacture, Sell Pfizer's Paxlovid
​​The company said Nirmatrelvir and Ritonavir tablets will soon be available in a combi-pack, sold under the brand name Paxzen, as a treatment option for patients with mild to moderate symptoms of Covid-19. While the price of medicine is yet to be decided, it will be manufactured at Zenara's USFDA-approved state-of-the-art facility in Hyderabad.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Jul 28, 2022 11:36 PM
Zenara Pharma gets CDSCO nod to launch Covid antiviral Paxlovid in India
Zenara Pharma gets CDSCO nod to launch Covid antiviral Paxlovid in India
The approval by the Central Drugs Standard Control Organization (CDSCO) has been granted under the emergency authorization route considering the unmet medical need.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Jul 28, 2022 7:56 PM
Zenara pharma to launch generic Paxlovid soon
Zenara pharma to launch generic Paxlovid soon
The company said that Nirmatrelvir and Ritonavir tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19 will be available soon.
The Economic Times
Comment
Share
Add a comment
Sid-display-image
Reputation: 8,698  •  Jul 28, 2022 3:52 AM

Pfizer, BioNTech start mid-phase trial for Omicron vaccine
American Pfizer Inc. and its German partner BioNTech SE announced on Wednesday that they initiated a "randomized, active-controlled, observer-blind" mid-stage vaccine trial for an unspecified Omicron variant of COVID-19.
......read more
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Jul 22, 2022 1:41 AM
US President Biden tests positive for COVID-19, has 'mild symptoms'
US President Biden tests positive for COVID-19, has 'mild symptoms'
White House Press Secretary Karine Jean-Pierre said that Biden was experiencing "mild symptoms" and has begun taking Paxlovid, an antiviral drug designed to reduce the severity of the disease.
The Economic Times
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 35,254  •  Jul 21, 2022 9:11 PM
AstraZeneca, Pfizer COVID-19 vaccines offer high protection 6 months after second dose: Study
AstraZeneca, Pfizer COVID-19 vaccines offer high protection 6 months after second dose: Study
The researchers used records on 1,951,866 (19.5 lakh) and 3,219,349 (32 lakh) adults who had received two doses of Pfizer and AstraZeneca vaccnes, respectively and 2,422,980 (24 lakh) unvaccinated adults.
The Economic Times
Comment
Share
Add a comment
Load More Posts